Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

  • Track 1-1Types of Research
  • Track 1-2Fundings in Cancer Research
  • Track 1-3Participation of Patients in Cancer Research
  • Track 1-4Future of Cancer Research
  • Track 2-1Dysplasia
  • Track 2-2Metaplasia
  • Track 2-3Hyperplasia
  • Track 2-4Genetic Changes
  • Track 2-5Solid Tumor Parts
  • Track 3-1Cancer Etiology
  • Track 3-2Health Disparities
  • Track 3-3Genetic and molecular epidemiology
  • Track 3-4Environmental Carcinogens
  • Track 3-5Gene-Environment Interactions
  • Track 4-1Breast cancer
  • Track 4-2Prostate cancer
  • Track 4-3Basal cell cancer
  • Track 4-4Colon cancer
  • Track 4-5Lymphoma
  • Track 5-1Case Reports on Cancer
  • Track 5-2Types of Case Reports
  • Track 5-3Clinical Case Reports
  • Track 5-4Medical Case Reports
  • Track 6-1Risk assessment, Diagnosis
  • Track 6-2Biomarkers in Cancer Medicine
  • Track 6-3Biomarkers in Medicine
  • Track 6-4Biomarkers in Cancer Research
  • Track 6-5Companion Biomarker
  • Track 7-1Surgical Method
  • Track 7-2Chemotherapy
  • Track 7-3Immunotherapy
  • Track 7-4Hormone therapy
  • Track 7-5Radiation therapy
  • Track 7-6Targeted therapy
  • Track 8-1Classes of Anti Cancerous Drug
  • Track 8-2Side Effects of Anti Cancerous Drug
  • Track 8-3Efficacy of Anti Cancerous Drug
  • Track 8-4Ovarian Cancer
  • Track 9-1Skin Cancer
  • Track 9-2Breast Cancer
  • Track 9-3Lung Cancer
  • Track 9-4Prostate Cancer
  • Track 10-1Use of Stem Cell in Cancer Treatment
  • Track 10-2Stem Cell Transplant Procedures
  • Track 10-3Stem Cell Transplant Side Effects
  • Track 10-4Types of Stem Cell Transplant
  • Track 10-5Challenges in Stem Cell Transplant
  • Track 11-1Use of Biomarkers in Cancer Research
  • Track 11-2Cancer Biomarker Discovery
  • Track 11-3Biomarker Development
  • Track 11-4Validation of Biomarkers
  • Track 11-5Availability of Cancer Biomarkers
  • Track 12-1Cancer Immunotherapy
  • Track 12-2Immunodiagnostic
  • Track 12-3Immunoediting
  • Track 12-4Future expansions in Cancer Immunology
  • Track 12-5Oncology Nursing Education
  • Track 13-1Cellular Immunotherapy
  • Track 13-2Antibody Therapy
  • Track 13-3Host-Tumour Relation
  • Track 13-4Clinical Cancer immunology
  • Track 14-1Cancer Stem Cells
  • Track 14-2Stem Cell Transplantation
  • Track 14-3Cancer stage and Diagnosis of Cancer
  • Track 14-4Future expansions in Cancer Diagnosis
  • Track 15-1Reoccurrence of Cancer
  • Track 15-2Protooncogenes
  • Track 15-3Oncogenes
  • Track 15-4Tumor Suppressor Genes
  • Track 15-5Cancer due to Mutations
  • Track 15-6Non- mutagenic cancer
  • Track 16-1Causes of Cancer
  • Track 16-2Anticancer Vegetables
  • Track 16-3Anticancer Fruits
  • Track 16-4Food as a source to prevent Cancer
  • Track 16-5 Can fruits and vegetables really be the good source to prevent cancer ?
  • Track 17-1Different Stages of Cancer
  • Track 17-2Reoccurrence of Cancer
  • Track 17-3Local & Malignant Cancer
  • Track 17-4Various treatment measures at different stages of cancer